Publications by authors named "S Prechtl"

Claim this Profile
D
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Keith Graham, Philip Lienau, Benjamin Bader, Stefan Prechtl, Jan Naujoks

Cell Chem Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase.
Volker K Schulze, Ulrich Klar, Dirk Kosemund, Antje M Wengner, Gerhard Siemeister, Stefan Prechtl

J Med Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors and .
Gerhard Siemeister, Anne Mengel, Amaury E Fernández-Montalván, Wilhelm Bone, Jens Schröder, Stefan Prechtl

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5.
Duy Nguyen, Clara Lemos, Lars Wortmann, Knut Eis, Simon J Holton, Stefan Prechtl

J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death.
Saskia Klutzny, Ralf Lesche, Matthias Keck, Stefan Kaulfuss, Andreas Schlicker, Stefan Prechtl

Cell Death Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis